Senseonics (NYSE:SENS) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Senseonics (NYSE:SENS) in a research note published on Sunday. The firm issued a sell rating on the stock.

Senseonics Stock Down 1.6 %

NYSE SENS traded down $0.01 on Friday, reaching $0.38. The company had a trading volume of 2,024,873 shares, compared to its average volume of 2,165,094. The firm has a 50-day moving average of $0.42 and a 200-day moving average of $0.50. Senseonics has a 1 year low of $0.37 and a 1 year high of $0.86. The firm has a market capitalization of $203.75 million, a PE ratio of -2.79 and a beta of 0.82. The company has a debt-to-equity ratio of 1.79, a current ratio of 3.96 and a quick ratio of 3.70.

Senseonics (NYSE:SENS) last announced its earnings results on Monday, May 13th. The company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). Senseonics had a negative return on equity of 202.32% and a negative net margin of 346.38%. The business had revenue of $5.05 million during the quarter, compared to analysts’ expectations of $4.76 million. On average, equities research analysts anticipate that Senseonics will post -0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of SENS. Vanguard Group Inc. raised its holdings in shares of Senseonics by 0.7% in the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock worth $11,963,000 after buying an additional 155,715 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Senseonics by 30.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock valued at $483,000 after buying an additional 211,128 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in Senseonics by 16.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after buying an additional 51,000 shares during the last quarter. Virtu Financial LLC acquired a new position in shares of Senseonics during the 1st quarter worth $162,000. Finally, State Board of Administration of Florida Retirement System acquired a new stake in shares of Senseonics during the 1st quarter worth about $91,000. 12.36% of the stock is owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.